Results 151 to 160 of about 10,351 (214)

Anti-Shigella activity and killing kinetics of compounds from MMV Pathogen and COVID Boxes: Identifying leads against Shigellosis. [PDF]

Curr Res Pharmacol Drug Discov
Tchokouaha Yamthe LR, Kengne Mediesse F, Melogmo Dongmo YK, Matchuenkam Gayap SR, Dize D, Tsouh Fokou PV, Boyom FF.   +6 more
europepmc   +1 more source

<i>Shigella sonnei</i> and <i>Shigella flexneri</i>: Epidemiology supporting development of cross-protective vaccines. [PDF]

Hum Vaccin Immunother
Caradonna V, Hunyady A, Nakakana U, Iturriza M, Micoli F, Rossi O, Mancini F.   +6 more
europepmc   +1 more source

Integrative MeRIP-Seq and RNA-Seq Analyses Reveal Innate Immune and Infection-Related Transcriptomic Changes upon METTL3 Knockout. [PDF]

Genes (Basel)
Tang Q, Hu Y, Zhu L, Liu Y, Zhang J, An Z, Dong Q, Cao C.   +7 more
europepmc   +1 more source

Isolation and characterization of lytic <i>Shigella</i> bacteriophages with rapid <i>in vitro</i> and <i>ex vivo</i> bactericidal activity. [PDF]

Front Cell Infect Microbiol
Shaheen N, Stricklin M, Kordesch M, Wang S.   +3 more
europepmc   +1 more source

Genomic and epidemiological characteristics of <i>Shigella boydii</i> in Australia, 1991-2022. [PDF]

Pathog Glob Health
Ibrahim AF, Ingle DJ, Webb JR, Howden BP, Andersson P, Polkinghorne BG, Wright R, Glass K, Kirk MD.   +8 more
europepmc   +1 more source